Costco Stock And Two Low Risk Leaders For Choppy Markets

VERTIV HOLDINGS LLC

VERTIV HOLDINGS LLC

VRT

0.00

Global bond yields have pushed higher this month as investors demand more compensation for inflation risk. When safer assets feel choppy, owning low risk leaders can help steady your portfolio without stepping out of the market. This screener focuses on companies with resilient balance sheets and lower risk scores. In this article you will see three of the most resilient stocks from the Low-Risk Leaders list.

The three stocks in this article are just a starting sample, and the full Low-Risk Leaders screen surfaces 77 more companies with equally compelling narratives that are not covered here. To identify and analyze the highest conviction opportunities for your own portfolio, head straight into the Low-Risk Leaders screener.

Vertiv Holdings Co (VRT)

Vertiv Holdings Co is a US$113.1b critical digital infrastructure supplier that keeps data centers, communication networks, and industrial sites powered, cooled, and online, which directly fits the Low-Risk Leaders focus on reliability. Its core offerings include UPS systems, rack power distribution, and air and liquid cooling, plus lifecycle and predictive maintenance services that help customers reduce downtime risk. Vertiv generates most of its revenue in the Americas at about US$7.5b, with sizeable exposure to Asia Pacific at roughly US$2.7b and Europe, the Middle East & Africa at about US$2.4b.

Vertiv may be worth a closer look if you want exposure to AI and cloud trends without owning chip stocks directly. The company supplies the power, cooling, and monitoring hardware that keeps high density data centers running, and couples that with lifecycle services that can help make those revenue streams more resilient over time. The trade off is a rich valuation and dependence on a small group of hyperscale customers, which could be challenging if spending slows. For investors willing to accept that tension, Vertiv provides a combination of critical infrastructure, strong profitability, and growing service exposure that many competitors are still working to match.

Vertiv is riding the AI and cloud buildout, yet its valuation, customer concentration, and service mix raise questions that most investors have not fully unpacked. Get the full story in the analysis report for Vertiv Holdings Co.

NYSE:VRT Earnings & Revenue Growth as at Aug 2026
NYSE:VRT Earnings & Revenue Growth as at Aug 2026

Build your own low risk infrastructure shortlist

Vertiv Holdings Co and the two other stocks in this list came from a single Simply Wall St screener, and you can set up your own filters just as easily. Use our flexible Screener to combine valuation, future growth, quality and risk metrics, or lean on any of our curated Investing Ideas for ready made shortlists.

Costco Wholesale (COST)

Costco Wholesale runs membership-only warehouse clubs that sell everything from groceries and fresh food to electronics, furniture, fuel, and travel services, with most of its US$293.6b revenue coming from these membership warehouses. The real anchor for the Low-Risk Leaders theme is the membership model itself, which creates recurring fee income and encourages high inventory turnover, helping to support steadier cash flows than many retailers. Costco has a market cap of about US$426.2b, reflecting investor confidence in the durability of that membership driven model across its large US and international footprint.

Costco Wholesale gives you exposure to a business where membership fees, high renewal rates and steady warehouse traffic have supported resilient earnings growth and a strong balance sheet. This is exactly what many investors look for when they want a foundation stock rather than a swing-for-the-fences idea. The trade off is that the stock now carries a premium valuation and depends on continued membership growth, international expansion and digital monetization to justify those expectations. How that balance between quality and price plays out, including the role of executive memberships, fuel traffic and competition from Sam's Club, is where the real story starts to get interesting.

Costco’s membership engine and premium valuation often look perfectly aligned. Yet the real story may be how far that model can stretch before returns and renewal economics decouple. Get the full context in the analysis report for Costco Wholesale.

NasdaqGS:COST P/E Ratio as at Aug 2026
NasdaqGS:COST P/E Ratio as at Aug 2026

Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals is a large biotechnology company focused on treating serious diseases, with a Low-Risk Leaders profile anchored in its approved cystic fibrosis medicines such as TRIKAFTA and KALYDECO. These CF therapies generate the company’s US$12.6b in pharmaceutical revenue, providing high margin, recurring cash flows that support a strong balance sheet. A growing pipeline in sickle cell disease, kidney disease, pain and other conditions adds longer term potential but also clinical and regulatory risk. The company has a market cap of about US$128.2b, which reflects the scale of its existing CF franchise alongside expectations for its broader portfolio.

Vertex Pharmaceuticals offers something rare in biotech for a foundation style holding. Investors get a proven CF franchise that generates high margin cash flows and supports strong returns on equity, yet there is still meaningful upside tied to newer launches like CASGEVY and JOURNAVX and an expanding nephrology and endocrinology pipeline. The catch is heavy dependence on CF drugs and the usual uncertainties around pricing, reimbursement and trial outcomes. For investors who want resilient earnings with carefully chosen growth options, the most important question is how long CF can anchor that profile as the next wave of therapies scales up. That is where the real analysis begins.

Vertex Pharmaceuticals appears to combine resilient CF cash flows with new launches that could reshape the story. To see how that growth pipeline compares with current expectations, go straight to the analyst forecasts for Vertex Pharmaceuticals.

NasdaqGS:VRTX Earnings & Revenue Growth as at Aug 2026
NasdaqGS:VRTX Earnings & Revenue Growth as at Aug 2026

Seeking Fresh Alternatives Before Others Do

Markets move quickly and the most compelling stock ideas can shift from quiet accumulation to full breakout before the crowd catches on. Scan these fresh lists while it still matters and get in early.

  • Target resilient income streams by reviewing a curated set of companies known for consistent payouts and balance sheet strength using the 10 dividend fortresses.
  • Spot potential future leaders in cutting edge computing by checking a focused group of under the radar enablers inside the 24 quantum computing stocks.
  • Ride early momentum in digital infrastructure by assessing a hand picked roster of enablers to AI demand through the 56 AI infrastructure stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.